What is Beam Therapeutics's price / sales?

Beam Therapeutics (BEAM) reported price / sales of 14.8× in Q1 2026.

How has Beam Therapeutics's price / sales changed year-over-year?

Beam Therapeutics's price / sales decreased by 51.7% year-over-year, from 30.7× to 14.8×.

What is the long-term trend for Beam Therapeutics's price / sales?

Over 5 years (2020 to 2025), Beam Therapeutics's price / sales has grown at a -84.6% compound annual growth rate (CAGR), from 231,775.3× to 20.1×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Beam Therapeutics BEAM Price / sales

Price / sales at other companies

Vertex PharmaceuticalsVRTX

9.3×-1.9×

Arrowhead ResearchARWR

14.1×+10.9×

CRISPR TherapeuticsCRSP

1,112.8×+1,035×

PTC TherapeuticsPTCT

6.8×+4.6×

BridgeBio PharmaBBIO

24.8×-26.8×

Protagonist TherapeuticsPTGX

90.8×+76.5×

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Calculated from Beam Therapeutics’s reported figures.

market cap/total revenue=14.8×

Based on the most recent quarter.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's price / sales?: Beam Therapeutics (BEAM) reported price / sales of 14.8× in Q1 2026.
How has Beam Therapeutics's price / sales changed year-over-year?: Beam Therapeutics's price / sales decreased by 51.7% year-over-year, from 30.7× to 14.8×.
What is the long-term trend for Beam Therapeutics's price / sales?: Over 5 years (2020 to 2025), Beam Therapeutics's price / sales has grown at a -84.6% compound annual growth rate (CAGR), from 231,775.3× to 20.1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.